PD 535 40 (Accupril 40 mg)
Generic Name: quinapril
Pill imprint PD 535 40 has been identified as Accupril 40 mg.
Accupril is used in the treatment of left ventricular dysfunction; diabetic kidney disease; high blood pressure; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Accupril 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- quinapril
- Imprint:
- PD 535 40
- Strength:
- 40 mg
- Color:
- Brown
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Parke-Davis
- National Drug Code (NDC):
- 00071-0535
- Inactive Ingredients:
- candelilla wax
crospovidone
gelatin
lactose
magnesium carbonate
magnesium stearate
ferric oxide red
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3445 | Physicians Total Care Inc (repackager) |
| 55289-0555 | PDRX Pharmaceuticals Inc (repackager) |
| 63874-0058 | Altura Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about Accupril (quinapril)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
